OR WAIT null SECS
April 26, 2025
Video
Gene therapy could revolutionize retinal disease treatment, promising consistent dosing, fewer injections, and improved patient outcomes, as highlighted by expert Christina Y. Weng.
April 16, 2025
Article
The study indicates which biomarkers should be prioritized to predict neovascular AMD and geographic atrophy.
April 10, 2025
Tailor discusses the future of AI in ophthalmology and beyond, and some of the challenges it may bring.
April 08, 2025
Our Q1 2025 recap for ophthalmology spotlights 5 regulatory updates, 5 key trial announcements, and two episodes of our flagship ophthalmology podcast.
March 05, 2025
Podcast
Veeral Sheth, MD, is joined by the CEO of Oculis to discuss the company's ophthalmic pipeline, including OCS-01 for DME and OCS-05 for acute optic neuritis.
March 04, 2025
The February 2025 month in review covers 7 key pipeline updates in ophthalmology, including regulatory approvals, label expansions, and topline trial results.
February 28, 2025
This FDA News Month in Review provides a round-up of regulatory decisions from February 2025.
February 16, 2025
Our top 5 headlines include a target date for a cholesterol-lowering drug, long-term dermatology data, and an expanded dosing label for geographic atrophy.
February 13, 2025
The FDA approved an expanded label for avacincaptad pegol, removing limitations on the duration of dosing beyond 12 months.
February 06, 2025
The January 2025 ophthalmology month in review highlights the latest from the FDA, key updates to the ophthalmic pipeline, and the latest episode of New Insight.
